Mitchell P. Kopin 13D and 13G filings for Tenax Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-13 06:39 am Purchase | 2023-02-03 | 13G | Tenax Therapeutics, Inc. TENX | Mitchell P. Kopin | 5,997 4.990% | 5,997 (New Position) | Filing |